These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Pathologic classification of rhabdomyosarcomas and correlations with molecular studies. Parham DM Mod Pathol; 2001 May; 14(5):506-14. PubMed ID: 11353062 [TBL] [Abstract][Full Text] [Related]
13. Sclerosing rhabdomyosarcoma in childhood: case report and review of the literature. Vadgama B; Sebire NJ; Malone M; Ramsay AD Pediatr Dev Pathol; 2004; 7(4):391-6. PubMed ID: 15383934 [TBL] [Abstract][Full Text] [Related]
14. Molecular testing of rhabdomyosarcoma in clinical trials to improve risk stratification and outcome: A consensus view from European paediatric Soft tissue sarcoma Study Group, Children's Oncology Group and Cooperative Weichteilsarkom-Studiengruppe. Hettmer S; Linardic CM; Kelsey A; Rudzinski ER; Vokuhl C; Selfe J; Ruhen O; Shern JF; Khan J; Kovach AR; Lupo PJ; Gatz SA; Schäfer BW; Volchenboum S; Minard-Colin V; Koscielniak E; Hawkins DS; Bisogno G; Sparber-Sauer M; Venkatramani R; Merks JHM; Shipley J Eur J Cancer; 2022 Sep; 172():367-386. PubMed ID: 35839732 [TBL] [Abstract][Full Text] [Related]
15. Rhabdomyosarcoma: From Obscurity to Clarity in Diagnosis … But With Ongoing Challenges in Management: The Farber-Landing Lecture of 2020. Parham DM; Giannikopoulos P Pediatr Dev Pathol; 2021; 24(2):87-95. PubMed ID: 33439112 [TBL] [Abstract][Full Text] [Related]